Guest Column

  • U.S. Medicine Prices: Watching from Europe with Trembling Knees Thursday, December 17th, 2015 | January 2016, Volume 2, Issue 1 | Peter Hokland, MD, DMedSci

    Working at the Dana-Farber Cancer Institute (then the Sidney Farber) in the Division of Tumor Immunology led by Stuart Schlossman, MD, in the early 1980s was a great experience for my wife and me – and perhaps an even greater one for our two young kids. The concept of Halloween, for one, was completely new […]

  • The Roadmap Forward in Follicular Lymphoma: Time for a Precision Approach Friday, November 20th, 2015 | December 2015, Volume 1, Issue 12 | Jonathan W. Friedberg, MD, MMSc

    Over the past two decades, improved diagnostic accuracy and novel therapeutic approaches have resulted in profound improvements in overall survival in patients with follicular lymphoma (FL). A 2013 study of patients diagnosed with FL demonstrated a median overall survival exceeding 18 years.1 That is nearly three times longer than that reported in a study of […]

1 of 1
back to top